Please assess the completion status of the following clinical trial:

Trial Title: Trusopt and Cosopt; Ocular Perfusion Pressure and Blood Flow: New Long-term Prospective Data

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~1. Age: 30 years or older.~2. Diagnosis: confirmed open-angle glaucoma in at least one eye:~   1. glaucomatous visual field loss on Humphrey 24-2 or 10-2 perimetry~  2. glaucomatous optic disc cupping~  3. agreement between two baseline exams for reliability~3. Best corrected visual acuity at least 20/60 in at least one eye.~4. Prior Humphrey visual fields demonstrate acceptable reliability standards.~Exclusion Criteria:~1. Extensive Humphrey visual field damage consisting of either a mean deviation (MD) \< -15 decibels or a clinically determined threat to fixation in both hemifields.~2. Evidence of exfoliation or pigment dispersion.~3. History of acute angle-closure or a narrow, occludable anterior chamber angle by gonioscopy.~4. History of chronic or recurrent inflammatory eye diseases (e.g., scleritis, uveitis).~5. History or signs of intraocular trauma.~6. Severe or potentially progressive retinal disease such as retinal degeneration, diabetic retinopathy, and retinal detachment.~7. Any abnormality preventing reliable applanation tonometry.~8. Current use of any ophthalmic or systemic steroid which may interfere with this investigation.~9. Cataract surgery within the past year.~10. Resting pulse \< 50 beats per minute.~11. Severe, unstable or uncontrolled cardiovascular, renal, or pulmonary disease.

- Gender: ALL
- Minimum Age: 30 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Glaucoma patients (Type: None): Patients with Glaucoma

Based on this trial design, predict the completion outcome and termination type (if applicable).